CNBX Pharmaceuticals's total assets for Q1 2026 were $11.16K, a decrease of -39.46% from the previous quarter. CNBX total liabilities were $2.58M for the fiscal quarter, a 2.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.